Dehydroepiandrosterone sulfate [651-48-9]
Cat# NB-64-15537-100mg
Size : 100mg
Brand : Neo Biotech
Dehydroepiandrosterone sulfate (Synonyms: Prasterone sulfate, PB-005, PB005, PB 005, DHEAS, DHEA sulfate)
Catalog No. T26366 Copy Product Info
Purity: 97.18%
Dehydroepiandrosterone sulfate (PB-005) influences the migration of neurons, arborization of dendrites, and formation of new synapses.
Select Batch
Purity:97.18%
Appearance:Solid
Color:White
Contact us for more batch information
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | Dehydroepiandrosterone sulfate (PB-005) influences the migration of neurons, arborization of dendrites, and formation of new synapses. |
| In vitro | Dehydroepiandrosterone sulfate selectively increases the length of neurites containing the dendritic marker MAP-2 and increases neuronal excitability when directly applied to septal-preoptic neurons[1]. |
| In vivo | Chronic administration of Dehydroepiandrosterone sulfate produces a dose-dependent effect on performance. In male Sprague-Dawley rats, Dehydroepiandrosterone sulfate (5-20 mg/kg; s.c.) is significantly effective in improving latency to reach the platform[3]. |
| Synonyms | Prasterone sulfate, PB-005, PB005, PB 005, DHEAS, DHEA sulfate |
| Molecular Weight | 368.49 |
| Formula | C19H28O5S |
| Cas No. | 651-48-9 |
| Smiles | 02[C@@]12CCC(=O)[C@@]1(C)CC[C@@]1(02)[C@@]2(02)CC=C2C[C@H](CC[C@]12C)OS(O)(=O)=O |
| Relative Density. | 1.1763 g/cm3 (Estimated) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 121.25 mg/mL (329.05 mM), Sonication is recommended. ![]() | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (8.96 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||||||||||||



